Tuberculosis and Respiratory Diseases

  • 제85권3호
  • /
  • Pages.279-282
  • /
  • 2022
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

Current Chronic Obstructive Pulmonary Disease Treatment Status in Asia: A Position Statement of the Asian Pacific Society of Respirology

  • Choi, Joon Young (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Milne, Stephen (University of British Columbia Centre for Heart Lung Innovation, St. Paul's Hospital) ;
  • Yunus, Faisal (Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan National Respiratory Center Hospital) ;
  • Rhee, Chin Kook (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Matsunaga, Kazuto (Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University)
  • 투고 : 2022.02.17
  • 심사 : 2022.04.19
  • 발행 : 2022.07.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Burney P, Jarvis D, Perez-Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis 2015;19:10-20. https://doi.org/10.5588/ijtld.14.0446
  2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease [Internet]. Global Initiative for Chronic Obstructive Lung Disease; 2020 [cited 2020 Dec 23]. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.
  3. Choi JY, Kim SY, Lee JH, Park YB, Kim YH, Um SJ, et al. Clinical characteristics of chronic obstructive pulmonary disease in female patients: findings from a KOCOSS cohort. Int J Chron Obstruct Pulmon Dis 2020;15:2217-24. https://doi.org/10.2147/COPD.S269579
  4. Matsunaga K, Hayata A, Akamatsu K, Hirano T, Tamada T, Kamei T, et al. Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: a multicenter cross-sectional CAP study. Respir Investig 2015;53:82-5. https://doi.org/10.1016/j.resinv.2014.10.006
  5. Lim R, Kerr M, Roughead EE. Use of medicines and health services for chronic obstructive pulmonary disease among a cohort of Australians over 50 years. Int J Chron Obstruct Pulmon Dis 2018;13:3085-93. https://doi.org/10.2147/COPD.S172495
  6. WHO report on the global tobacco epidemic 2019: offer help to quit tobacco use. Geneva: World Health Organization; 2019.
  7. Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 2010;170:560-5. https://doi.org/10.1001/archinternmed.2010.17
  8. Bhome AB. COPD in India: iceberg or volcano? J Thorac Dis 2012;4:298-309. https://doi.org/10.3978/j.issn.2072-1439.2012.03.15
  9. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007;176:753-60. https://doi.org/10.1164/rccm.200612-1749OC
  10. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Molken MR. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis 2010;5:435-44.
  11. Jo YS, Kim YH, Lee JY, Kim K, Jung KS, Yoo JH, et al. Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction. Int J Chron Obstruct Pulmon Dis 2018;13:2261-9. https://doi.org/10.2147/COPD.S163000